tiprankstipranks
Trending News
More News >
Community Health (CYH)
NYSE:CYH
Advertisement

Community Health (CYH) AI Stock Analysis

Compare
416 Followers

Top Page

CYH

Community Health

(NYSE:CYH)

Rating:51Neutral
Price Target:
$2.50
▼(-10.39% Downside)
Community Health's overall stock score reflects a challenging financial position with high leverage and negative equity, offset by strong cash flow performance. The technical indicators suggest a bearish trend, while valuation metrics highlight unprofitability. Positive corporate events and strategic initiatives provide some optimism, but the cautious outlook from the earnings call tempers expectations.
Positive Factors
Asset Divestitures
CYH announced an agreement to sell 80% of its ownership interest in Cedar Park Regional Medical Center to Ascension Health for proceeds of $460MM, which is viewed as a positive deal as it was able to sell these assets at a solid valuation.
Balance Sheet Improvement
The divestitures will slightly reduce leverage, which is beneficial for the company's financial health.
Negative Factors
CEO Transition
The CEO transition adds uncertainty at a time when the hospital industry is facing new regulatory challenges.
EBITDA and Financial Performance
The company's Q2 trends resulted in an EBITDA miss, contributing to a less favorable outlook.
Regulatory and Legislative Risks
There is uncertainty in future earnings due to legislative impacts and scheduled subsidy expirations, which may increase the company's leverage ratio.

Community Health (CYH) vs. SPDR S&P 500 ETF (SPY)

Community Health Business Overview & Revenue Model

Company DescriptionCommunity Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
How the Company Makes MoneyCommunity Health generates revenue through a combination of government funding, private insurance reimbursements, and direct payments from patients. Key revenue streams include capitated payments from managed care organizations, which provide a fixed amount per patient for a defined set of services, and fee-for-service payments for specific medical procedures and consultations. Additionally, the organization engages in partnerships with local health departments and philanthropic organizations, enabling it to secure grants and funding aimed at enhancing community health initiatives. These partnerships not only bolster its financial stability but also expand its reach and impact within the communities it serves.

Community Health Earnings Call Summary

Earnings Call Date:Jul 23, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 22, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted positive developments in revenue growth and strategic initiatives but faced challenges with declining patient volumes and a decrease in EBITDA margin. The revised financial guidance reflects a cautious outlook due to external factors affecting healthcare demand.
Q2-2025 Updates
Positive Updates
Revenue Growth
Same-store net revenue increased 6.5% year-over-year, driven by rate growth including revenue recognition under Medicaid state-directed payment programs in New Mexico and Tennessee.
Debt Refinancing and Divestitures
CHS completed the divestiture of Cedar Park Regional Medical Center for $436 million and refinanced $700 million of 8% Senior Secured Notes, improving maturity and leverage profile.
Provider Recruitment and Expansion
Over 200 new providers are scheduled to start in the second half of 2025, with new outpatient access points set to open, including ambulatory surgery centers in key markets.
Negative Updates
Volume Decline
Inpatient admissions only increased 0.3%, with adjusted admissions declining 0.7%, surgeries down 2.5%, and ER visits down 1.9% due to lower-than-expected patient volumes.
EBITDA Margin Decrease
Adjusted EBITDA for the second quarter was $380 million, down from $387 million the prior year, with margins slightly decreasing from 12.3% to 12.1% year-over-year.
Revised Financial Guidance
CHS tightened its adjusted EBITDA range for 2025 to $1.45 billion to $1.55 billion due to lower-than-expected volume growth and impacts from the Cedar Park divestiture.
Company Guidance
During the Community Health Systems second quarter 2025 earnings call, several metrics were highlighted regarding the company's performance and future outlook. The same-store net revenue increased by 6.5% year-over-year, while inpatient admissions rose by 0.3%. However, adjusted admissions declined by 0.7%, with surgeries decreasing by 2.5% and ER visits down by 1.9%. The adjusted EBITDA for the second quarter was reported at $380 million, down from $387 million in the prior year, with a margin of 12.1% versus 12.3% in the previous year. The company also reported year-to-date cash flows from operations at $208 million, which included $74 million in outflows for taxes on gains from sales. Looking ahead, the company tightened its full-year adjusted EBITDA guidance to a range of $1.45 billion to $1.55 billion due to lower-than-expected volume growth and strategic divestitures. Additionally, it was noted that the Budget Reconciliation Act could potentially reduce EBITDA by $300 million to $350 million over the next 13 years, although no impact is expected in 2025 or 2026.

Community Health Financial Statement Overview

Summary
Community Health is experiencing financial challenges, particularly highlighted by its negative net income and equity. While revenue shows modest growth, profitability and leverage are areas of concern. The positive operating cash flows provide a foundation for improvement, but strategic financial restructuring is necessary.
Income Statement
45
Neutral
The company's revenue has shown marginal growth over the years, with a TTM revenue of $12.654 billion. However, the net income has turned negative in recent years, resulting in a net loss. This is concerning as it indicates declining profitability, despite the gross profit margin of 37.08% and EBITDA margin of 8.32% in the TTM period. The EBIT margin stands at 4.78%, showing operational challenges. While revenue growth is a positive sign, the company's profitability metrics need improvement to enhance financial stability.
Balance Sheet
30
Negative
The balance sheet reveals significant financial distress, marked by negative stockholders' equity, which indicates insolvency. The debt-to-equity ratio is not calculable due to the negative equity, but the high total debt of $12.1 billion in the TTM period reflects leverage concerns. Return on equity is negative due to the net loss, and the equity ratio is also skewed by negative equity. Overall, the company's balance sheet highlights substantial financial risk with a need for restructuring.
Cash Flow
55
Neutral
Operating cash flow has been positive, with a TTM figure of $504 million, indicating some level of cash generation. However, the free cash flow, although positive at $152 million, has seen fluctuations, with a notable improvement from previous negative periods. The free cash flow to net income ratio is not favorable due to the net loss, but the operating cash flow to net income ratio is positive, showing the company can generate cash despite net losses. Cash flow management needs to focus on consistent positive free cash flow.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue12.63B12.49B12.21B12.37B11.79B
Gross Profit10.69B5.08B4.91B5.08B4.42B
EBITDA1.07B1.54B1.74B1.93B2.02B
Net Income-516.00M-133.00M46.00M230.00M511.00M
Balance Sheet
Total Assets14.05B14.46B14.67B15.22B16.01B
Cash, Cash Equivalents and Short-Term Investments37.00M38.00M118.00M507.00M1.68B
Total Debt12.10B12.17B12.39B12.82B12.88B
Total Liabilities15.37B15.28B15.40B16.03B17.06B
Stockholders Equity-1.91B-1.39B-1.37B-1.37B-1.63B
Cash Flow
Free Cash Flow120.00M-257.00M-124.00M-603.00M1.74B
Operating Cash Flow480.00M210.00M300.00M-131.00M2.18B
Investing Cash Flow-275.00M-26.00M-259.00M-524.00M177.00M
Financing Cash Flow-206.00M-264.00M-430.00M-514.00M-895.00M

Community Health Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.79
Price Trends
50DMA
3.07
Negative
100DMA
3.15
Negative
200DMA
3.20
Negative
Market Momentum
MACD
-0.08
Negative
RSI
49.32
Neutral
STOCH
60.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CYH, the sentiment is Neutral. The current price of 2.79 is above the 20-day moving average (MA) of 2.62, below the 50-day MA of 3.07, and below the 200-day MA of 3.20, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 49.32 is Neutral, neither overbought nor oversold. The STOCH value of 60.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CYH.

Community Health Risk Analysis

Community Health disclosed 38 risk factors in its most recent earnings report. Community Health reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Community Health Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$1.12B109.332.28%5.17%-65.33%
56
Neutral
$779.90M18.62-40.13%-14.33%-398.68%
53
Neutral
$402.48M-21.72%-0.39%-1408.40%
51
Neutral
$7.83B-0.18-40.10%2.29%21.46%-2.03%
51
Neutral
$381.12M39.18%0.80%-95.01%
47
Neutral
$523.85M-12.03%12.19%-1.59%
45
Neutral
$433.44M-1.96%-24.30%-210.27%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CYH
Community Health
2.79
-2.73
-49.46%
AMN
AMN Healthcare Services
20.11
-32.85
-62.03%
CCRN
Cross Country Healthcare
13.20
-1.91
-12.64%
HCSG
Healthcare Services
15.58
4.72
43.46%
INNV
InnovAge Holding
3.96
-2.32
-36.94%
EHAB
Enhabit, Inc
8.00
-0.54
-6.32%

Community Health Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Community Health Completes $1.79 Billion Notes Offering
Positive
Aug 12, 2025

On August 12, 2025, Community Health Systems, Inc. completed its offering of $1.79 billion in 9.750% Senior Secured Notes due 2034, which are guaranteed by the company and its subsidiaries. The proceeds from this offering, along with cash on hand, were used to repurchase a significant portion of its outstanding 5.625% Senior Secured Notes due 2027, with plans to refinance the remaining balance. This strategic financial maneuver aims to optimize the company’s debt structure and improve its financial flexibility.

Private Placements and Financing
Community Health Prices $1.79 Billion Senior Notes
Positive
Jul 29, 2025

On July 28, 2025, Community Health Systems, Inc. announced that its subsidiary priced an offering of $1,790 million in Senior Secured Notes due 2034, an increase from the initially proposed $1,500 million. The proceeds will be used to refinance existing notes due in 2027. Additionally, the company launched a cash tender offer for its 2027 Notes, increasing the offer size by $287 million. This financial maneuver aims to strengthen the company’s financial position by managing its debt obligations more effectively.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Community Health Reports Strong Q2 2025 Financial Results
Positive
Jul 23, 2025

Community Health Systems, Inc. reported its financial results for the second quarter ending June 30, 2025, showing a significant turnaround with a net income of $282 million compared to a net loss in the same period of 2024. The company completed significant financial transactions, including the offering of $700 million in senior secured notes and the redemption of existing notes, which resulted in a net pre-tax gain from early debt extinguishment. Additionally, the company divested several hospital interests and entered into an agreement with Labcorp to sell select assets of its ambulatory outreach laboratory services for $195 million. These actions reflect the company’s strategic initiatives to strengthen its financial position and focus on core operations.

Executive/Board Changes
Community Health Announces CEO Retirement and Leadership Changes
Neutral
Jul 23, 2025

On July 23, 2025, Community Health Systems announced the retirement of Tim L. Hingtgen as CEO and board member, effective September 30, 2025. Hingtgen’s departure is amicable, and he will continue to advise the company as a consultant. Kevin J. Hammons, currently President and CFO, will become Interim CEO, and Jason K. Johnson will step in as Interim CFO. These leadership changes are expected to ensure a seamless transition and continued focus on enhancing patient care and company performance.

M&A TransactionsBusiness Operations and Strategy
Community Health Sells Lab Assets to Labcorp
Neutral
Jul 22, 2025

On July 22, 2025, Community Health Systems, Inc. announced a definitive agreement to sell select assets of its ambulatory outreach laboratory services to Labcorp for $195 million. This transaction, expected to close in the fourth quarter of 2025, aims to enhance patient and provider access to Labcorp’s comprehensive testing services while allowing CHS to focus on its core healthcare services. The agreement includes a non-competition clause and plans for a smooth transition to maintain service continuity.

M&A Transactions
Community Health Sells Cedar Park Stake for $436M
Neutral
Jul 1, 2025

On June 30, 2025, Community Health Systems, Inc. completed the sale of its 80% ownership interest in the Cedar Park Health System joint venture to Ascension Health for $436 million in cash. This transaction, which was initially agreed upon in April 2025, marks a significant disposition for CHS, potentially impacting its financial structure and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025